• Introduced
    Jan 12, 2026
  • Passed Senate
    Feb 06, 2026
  • Passed House
  • Became Law
SB 271
Virginia Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Prescription Drug Affordability Board; established, drug cost affordability review, report.
Last Action See all actions
Senate • Feb 06, 2026: Read third time and passed Senate (31-Y 8-N 0-A)
Latest Bill Text See all bill texts

Summary

Comments on SB 271

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Feb 06, 2026 | Senate
    • Read third time and passed Senate (31-Y 8-N 0-A)
  • Feb 05, 2026 | Senate
    • Read second time
    • Commerce and Labor Amendments agreed to (Voice Vote)
    • Engrossed by Senate as amended (Voice Vote)
  • Feb 04, 2026 | Senate
    • Rules suspended
    • Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
    • Passed by for the day Block Vote (Voice Vote)
  • Feb 03, 2026 | Senate
    • Reported from Finance and Appropriations (9-Y 5-N 1-A)
  • Jan 27, 2026 | Senate
    • Fiscal Impact Statement from Department of Planning and Budget (SB271)
  • Jan 26, 2026 | Senate
    • Senate committee offered
    • Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A)
  • Jan 22, 2026 | Senate
    • Rereferred from Education and Health to Commerce and Labor (14-Y 0-N)
  • Jan 12, 2026 | Senate
    • Prefiled and ordered printed; Offered 01-14-2026 26105318D
    • Referred to Committee on Education and Health